Lake Consumer Products to launch vH essentials PMS Relief Formula
JACKSON, Wis. — Lake Consumer Products, a subsidiary of Wisconsin Pharmacal Co., on Thursday acquired the exclusive North American rights to an over-the-counter product that addresses many of the key symptoms associated with premenstrual syndrome. Lake Consumer Products acquired the license from Back Bay Scientific.
Lake Consumer Products plans to launch the product, previously known as PMS Escape, under the trade name vH essentials PMS Relief Formula.
"Lake Consumer Products is excited about bringing this proven technology to market," said Jody Currie, director of innovation and business development at Wisconsin Pharmacal Co. "We believe this formula has the potential to positively impact the health and wellbeing of millions of women."
The PMS Relief Formula that will be marketed under the vH essentials brand consists of complex carbohydrates that work naturally with the body to increase, indirectly, the synthesis and activity of the neurotransmitter serotonin. Reduced levels of brain serotonin have been linked with PMS-associated mood disturbances, such as anxiety, anger, poor impulse control, an inability to concentrate and appetite changes.
In two clinical trials, the product improved typical PMS symptoms, such as anger, tension and confusion, for about three hours after consumption of the product. In addition, self-reported cravings for sweet and starchy foods also were significantly diminished, the company stated.
PQA launches a new quality measurement initiative aimed at improving adult immunizations data capture
SPRINGFIELD, Va. — The Pharmacy Quality Alliance has developed and launched a new quality measurement initiative, aimed at narrowing gaps in measurement and reporting for adult immunizations. The PQA Adult Immunization Task Force will convene regularly over the next 12- to 18-month period.
The task force recently assembled in Arlington, Va., on June 17 for its initial in-person meeting. The meeting received wide participation and consisted of a broad group of stakeholders, including the Centers for Disease Control and Prevention, Association of State and Territorial Health Officials, National Association of County and City Health Officials, Immunization Action Coalition, American Immunization Registry Association, national and state pharmacy associations, national pharmacy chains, independent pharmacists, academia, health plans and technology companies.
"As long as gaps in pharmacy-based immunization measurement and reporting remain, the ability of population health professionals to meet population prevention and wellness goals will continue to be called into question," said PQA executive director Laura Cranston. "The organization of this task force presents a significant opportunity to address these gaps and offer solutions for overcoming current barriers."
Two co-chairs are leading this effort — Mitchel Rothholz, chief strategy officer at the American Pharmacists Association, and Jeff Goad, professor and chair of the Department of Pharmacy Practice at Chapman University School of Pharmacy. PQA's director of Quality Strategies, Sam Stolpe, is the staff liaison for the task force.
At the recent meeting, the task force worked together to identify and address a variety of challenges within existing and proposed immunization reporting standards. The discussion focused on developing best practice recommendations and identifying measure concept work areas that will be implementable within the pharmacy practice setting, and that are translatable to other healthcare settings. The group formulated several recommendations for methods that will allow for better data capture through utilization of registries and standardization of documentation. Key work areas identified by the task force were prioritized, and will be the topic of the task force's ongoing telephonic efforts moving forward.
The task force has emphasized the need to align with priority areas addressed through other national-level organizations, such as the National Quality Forum Adult Immunization Committee, ACIP guidelines and NVAC standards.
The task force will next convene in person at a meeting to be held in the first quarter of next year. The measures concepts developed by the task force will follow the normal PQA measure development process, with a PQA member endorsement vote to be conducted in the fall of 2015.
Breg launches brace for sufferers of patella mal-tracking
CARLSBAD, Calif. — Breg on Thursday announced the launch of the FreeRunner knee brace with new innovations to help people, particularly runners, who suffer from patella mal-tracking return to active lifestyles. FreeRunner's patent-pending design acts on knee anatomy differently than other braces, providing support when patients need it most, and the ability to move normally when they don't.
Patellofemoral issues are the most common cause of knee pain seen by healthcare providers, according to the company. More than 2.5 million runners are diagnosed with patellofemoral pain syndrome every year. It is typically caused by overuse, injury, excess weight, muscle imbalance or a knee cap that is misaligned. Common examples of patella mal-tracking are patella dislocation, runner's knee and patellar tendonitis, among other conditions.
"Working with Breg on this brace is my first experience with a manufacturer partnering with clinicians to design a better product," said Jill Monson of Monson Orthopaedic Consulting. "The team really listened to relevant clinical needs and goals of patients, and helped develop a brace design rooted in known patellofemoral joint biomechanics."
Unlike other patellofemoral braces, FreeRunner provides maximum stabilization of the patella when the leg is extended, helping to keep the knee cap in place when it is most vulnerable to mal-tracking or dislocation. The brace offloads pressure when the leg is bent in flexion and the patella is not as unstable. This allows freedom of movement without sacrificing support.
"Patellofemoral braces have not changed much in the last 20 years," said Brad Lee, president and CEO of Breg. "Our new FreeRunner challenges the outdated way of bracing these conditions. It is highly functional, comfortable and non-binding during activity. We set out to make a brace that works and people want to wear. We believe we've achieved that goal."
At 7 oz., FreeRunner is lightweight and low-profile for minimal interference during activities. The brace incorporates new, breathable Smart-Zone compression fabrics that direct moderate compression for anatomic support where needed, and light compression over the patella and the popliteal space at the back of the knee for a non-binding fit.
Loading Post Please Wait...